The Pharmacist’s Role in Managing Disease-Modifying Therapies in Adults With Multiple Sclerosis

The Pharmacist’s Role in Managing Disease-Modifying Therapies in Adults With Multiple Sclerosis is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.

Published Date: May 31, 2019
Expiration Date: May 31, 2020

Credits: 1.0 hours (0.10 ceu)

Goal:
To educate pharmacists about MS pathophysiology and the new American Academy of Neurology recommendations for the use of disease-modifying therapies (DMTs) in adults.

Educational Objectives:
Upon completion of this activity, participants should be better able to:
• Describe the pathophysiological mechanisms that contribute to multiple sclerosis (MS)
• Evaluate the safety and efficacy of available disease-modifying therapies
• Employ care coordination strategies that emphasize multidisciplinary collaboration and advocacy for individuals with MS
• Define the pharmacist's role in providing drug management and administrative support to people receiving MS therapy and their providers

Additional details will be posted as soon as information is available.